Chapter 9: GERM CELL MUTAGENICITY
|
|
|
- Brianna Hardy
- 9 years ago
- Views:
Transcription
1 Chapter 9: GERM CELL MUTAGENICITY DEFINITIONS 1. The classification system is primarily concerned with chemicals which may cause mutations in the germ cells of humans and these mutations can be transmitted to the progeny. However, mutagenicity/genotoxicity tests in vitro and in mammalian somatic cells in vivo will also be considered in the sub-divisions of the classification system. 2. In the present context, commonly found definitions of the terms mutagenic, mutagen, mutations and genotoxic are used, and a mutation is defined here as a permanent change in the amount or structure of the genetic material in a cell. 3. The term mutation applies both for heritable genetic changes that may be manifested at the phenotypic level, and for the underlying DNA modifications when known (including, for example, specific base pair changes and chromosomal translocations). The term mutagenic and mutagen will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms. 4. The more general terms genotoxic and genotoxicity apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects. CONSIDERATIONS 5. The purpose of the harmonised scheme for the classification of chemicals which may cause heritable mutations in germ cells in humans is to provide a common ground which could be used internationally for the classification of mutagens. All tests conducted according to validated and internationally accepted test guidelines are acceptable for the purpose of classifying substances. 6. To arrive at that classification scheme, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests may also be considered. 7. The system is hazard based, classifying chemicals on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of chemical substances. CLASSIFICATION CRITERIA FOR SUBSTANCES 8. The classification system comprises two different classes of germ cell mutagens to accommodate the weight of evidence available. The two-category system is described in the following.
2 CATEGORY 1: CHEMICALS KNOWN TO INDUCE HERITABLE MUTATIONS OR TO BE REGARDED AS IF THEY INDUCE HERITABLE MUTATIONS IN THE GERM CELLS OF HUMANS. CATEGORY 1A: Chemicals known to induce heritable mutations in germ cells of humans Criteria: Positive evidence from human epidemiological studies. CATEGORY 1B: Chemicals which should be regarded as if they induce heritable mutations in the germ cells of humans. Criteria: CATEGORY 2: - Positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or - Positive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. This supporting evidence may, for example, be derived from mutagenicity/genotoxic tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or - Positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people. CHEMICALS WHICH CAUSE CONCERN FOR MAN OWING TO THE POSSIBILITY THAT THEY MAY INDUCE HERITABLE MUTATIONS IN THE GERM CELLS OF HUMANS. Positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from: - Somatic cell mutagenicity tests in vivo, in mammals; or - Other in vivo somatic cell genotoxicity tests which are to be supported by positive results from in vitro mutagenicity assays Nota Bene: - Chemicals which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, should be considered for classification as Category 2 mutagens. Rationale 9. Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in OECD Test Guidelines. Evaluation of the test results should be done using expert judgement and all the available evidence should be weighed for classification. 2
3 10. Examples of in vivo heritable germ cell mutagenicity tests are: Rodent dominant lethal mutation test (OECD 478) Mouse heritable translocation assay (OECD 485) Mouse specific locus test 11. Examples of in vivo somatic cell mutagenicity tests are: Mammalian bone marrow micronucleus test (OECD 474) Mammalian bone marrow chromosome aberration test (OECD 475) Mouse spot test (OECD 484) Mammalian erythrocyte micronucleus test (OECD 474) 12. Examples of mutagenicity/genotoxicity tests in germ cells are: A) Mutagenicity tests: Mammalian spermatogonial chromosome aberration test (OECD 483) Spermatid micronucleus assay B) Genotoxicity tests: Sister chromatid exchange analysis in spermatogonia Unscheduled DNA synthesis test (UDS) in testicular cells 13. Examples of genotoxicity tests in somatic cells are: Liver Unscheduled DNA Synthesis (UDS) in vivo (OECD 486) Mammalian bone marrow sister chromatid exchanges (SCE) 14. Examples of in vitro mutagenicity tests are: In vitro mammalian chromosome aberration test (OECD 473) In vitro mammalian cell gene mutation test (OECD 476) Bacterial reverse mutation tests (OECD 471) 15. The classification of individual substances should be based on the total weight of evidence available, using expert judgement. In those instances where a single well-conducted test is used for classification, it should provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the chemical compared to the route of human exposure should also be taken into account. CLASSIFICATION CRITERIA FOR MIXTURES Classification of Mixtures When Data are Available for the Complete Mixture. 16. Classification of mixtures will be based on the available test data of the individual constituents of the mixture using cut-off values/concentration limits for the components of the mixture. The classification may be modified on a case-by-case basis based on the available test data for the mixture as a whole. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations and analysis (e.g., statistical analysis, test sensitivity) 3
4 of germ cell mutagenicity test systems. Adequate documentation supporting the classification should be retained and made available for review upon request. Classification of Mixtures When Data are not Available for the Complete Mixture. Bridging Principles 17. Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, this data will be used in accordance with the following agreed bridging rules. This ensures that the classification process uses the available data to the greatest extent possible in characterising the hazards of the mixture without the necessity for additional testing in animals. Dilution 18. If a mixture is diluted with a diluent which is not expected to affect the germ cell mutagenicity of other ingredients, then the new mixture may be classified as equivalent to the original mixture. Batching 19. The germ cell mutagenic potential of one production batch of a complex mixture can be assumed to be substantially equivalent to that of another production batch of the same commercial product produced by and under the control of the same manufacture unless there is reason to believe there is significant variation in composition such that the germ cell mutagenic potential of the batch has changed. If the latter occurs, a new classification is necessary. Substantially similar mixtures 20. Given the following: a). Two mixtures: i.) A + B ii.) C + B b). The concentration of mutagen Ingredient B is the same in both mixtures. c). The concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii). d). Data on toxicity for A and C are available and substantially equivalent, i.e. they are not expected to affect the germ cell mutagenicity of B. If mixture (i) is already classified by testing, mixture (ii) can be assigned the same category. Classification of Mixtures When Data are Available for all Components or Only for Some Components of the Mixture. 21. The mixture will be classified as a mutagen when at least one ingredient has been classified as a Category 1 or Category 2 mutagen and is present at or above the appropriate cut-off value/concentration limit as mentioned in Table 1 below for Category 1 and 2 respectively. 4
5 Table 1: Cut-off values/concentration limits of ingredients of a mixture classified as germ cell mutagens that would trigger classification of the mixture. Ingredient classified as: Cut-off/concentration limits triggering classification of a mixture as: Category 1 mutagen Category 2 mutagen Category 1 mutagen 0.1 % - Category 2 mutagen - 1.0% Note: The cut-off values/concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units). HAZARD COMMUNICATION Allocation of Label Elements 22. General and specific considerations concerning labelling requirements are provided in Chapter 4. Annex 5 contains examples of precautionary statements and pictograms which can be used where allowed by the competent authority. Additional reference sources providing advice on the use of precautionary information is also included. Table 2: Label Elements of Germ cell mutagenicity Symbol Category 1A Category 1B Category 2 New health hazard New health hazard New health hazard symbol symbol symbol Signal Word Danger Danger Warning Hazard Statement May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) 5
6 DECISION LOGIC AND GUIDANCE Decision Logic N Is there reliable evidence of a mutagenic effect in the germ cells of humans? YES Class 1A NO Is there adequate evidence of a mutagenic effect in the germ cells of mammals in vivo or an mutagenic effect in vivo in somatic cells of mammals combined with a potential to cause mutations in germ cells or mutagenic effects in germ cells of humans without demonstrationof transmission NO YES Class 1B Is there adequate evidence of a mutagenic effect in vivo in somatic cells of mammals or a genotoxic effect in vivo in somatic cells of mammals supported by in vitro mutagenicity? yes Class 2 Substance is not classified for mutagenicity NO 6
7 Guidance Explanatory Note 23. It becomes increasingly clear that the process of chemical-induced tumorigenesis in man and animals involves (an accumulation of) genetic changes in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of chemicals in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these chemicals as carcinogens (cf. chapter Carcinogenicity ). SUMMARY TABLE EXAMPLES Examples mutagenicity classification Substance 1: positive in vitro mammalian mutagenicity assays and has a SAR to known germ cell mutagens. Classification: class 2. Substance 2: positive in vitro mammalian mutagenicity assays and positive in a UDS test in vivo. Classification: class 2. Substance 3: positive in vitro mammalian mutagenicity assays and positive in a mammalian bone marrow chromosome aberration test in vivo. Classification: Class 2 Substance 4: positive in vivo in somatic cells and positive in a UDS test in germ cells. Classification: Class: 1B NB At the moment there are no known 1A substances When present in a mixture the cut-off values / concentration limits for a Class 1 mutagen is 0.1%, for a Class 2 mutagen 1.0% (Table 1). The classified substances and preparations are labelled according Table 2 7
Chapter 12: SPECIFIC TARGET ORGAN SYSTEMIC TOXICITY (TOST) FOLLOWING A SINGLE EXPOSURE
Chapter 12: SPECIFIC TARGET ORGAN SYSTEMIC TOXICITY (TOST) FOLLOWING A SINGLE EXPOSURE DEFINITIONS 1. Classification identifies the chemical substance as being a specific target organ/systemic toxicant
PART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B
PART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B A. EXPLANATORY NOTE For the purpose of this General Introduction the following nymbering applies:
Chapter 13: SPECIFIC TARGET ORGAN SYSTEMIC TOXICITY (TOST) FOLLOWING REPEATED EXPOSURE
Chapter 13: SPECIFIC TARGET ORGAN SYSTEMIC TOXICITY (TOST) FOLLOWING REPEATED EXPOSURE DEFINITIONS 1. Classification identifies the chemical substance as being a specific target organ/systemic toxicant
PART 3 HEALTH HAZARDS
PART 3 HEALTH HAZARDS - 107 - CHAPTER 3.1 ACUTE TOXICITY 3.1.1 Definition Acute toxicity refers to those adverse effects occurring following oral or dermal administration of a single dose of a substance,
Work Health and Safety Regulations: Classification and labelling for workplace hazardous chemicals
code* word Class Category Code* Text Unstable explosive H200 Unstable explosive Division 1.1 H201 Explosive; mass explosion hazard Division 1.2 H202 Explosive; severe projection hazard Explosives Division
ICH guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human use
June 2012 EMA/CHMP/ICH/126642/2008 ICH guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human use Step 5 Transmission to CHMP March 2008 Adoption by CHMP
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S2(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDANCE ON GENOTOXICITY TESTING AND DATA INTERPRETATION
The Globally Harmonised System and Chemical Regulation: Challenges for the Cleaning Industry. Background of the new legislation
The Globally Harmonised System and Chemical Regulation: Challenges for the Cleaning Industry Background of the new legislation The Globally Harmonized System of Classification seeks to protect people and
PART 3 HEALTH HAZARDS
PART 3 HEALTH HAZARDS CHAPTER 3.1 ACUTE TOXICITY 3.1.1 Definition Acute toxicity refers to those adverse effects occurring following oral or dermal administration of a single dose of a substance, or multiple
Brussels, XXX [ ](2015) XXX draft ANNEX 1
EUROPEAN COMMISSION Brussels, XXX [ ](2015) XXX draft ANNEX 1 ANNEX EN EN ANNEX 'ANNEX VIII HARMONISED INFORMATION RELATING TO EMERGENCY HEALTH RESPONSE AND PREVENTATIVE MEASURES 1. Application PART A
Chapter 14: HAZARDOUS TO THE AQUATIC ENVIRONMENT
Chapter 14: HAZARDOUS TO THE AQUATIC ENVIRONMENT DEFINITIONS AND DATA REQUIREMENTS 1. The basic elements for use within the harmonised system are: - acute aquatic toxicity; - potential for or actual bioaccumulation;
Health and Safety Guidance
Health and Safety Guidance Guidance on the Classification, Labelling and Packaging (CLP) Regulations GUIDANCE/29/CLP/11 This guidance is aimed at those handling hazardous chemicals; from single substances
REACH and GHS. GHS: Core Elements of the New System: - Physical Hazards - Health Hazards - Environmental Hazards
REACH and GHS GHS: Core Elements of the New System: - Physical Hazards - Health Hazards - Environmental Hazards Dr. Helmut Fleig Product Safety Regulations, Toxicology and Ecology Vienna, Hofburg, March
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Biological importance of metabolites. Safety and efficacy aspects
Biological importance of metabolites Safety and efficacy aspects Bernard Walther Technologie Servier Biological importance of metabolites Safety testing of drug metabolites Bioanalytical strategy Structural
HazCom 2012: Overview of OSHA s Revised Hazard Communication Standard
APPLIEDSAFETY +ERGONOMICS HazCom 2012: Overview of OSHA s Revised Hazard Communication Standard INTRODUCTION Information about chemicals in U.S. workplaces has been regulated by the Occupational Safety
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Copyright@United Nations, 2011. All rights reserved. ANNEX 2 CLASSIFICATION AND LABELLING SUMMARY TABLES
ANNEX CLASSIFICATION AND LABELLING SUMMARY TABLES Annex CLASSIFICATION AND LABELLING SUMMARY TABLES A. Explosives (see Chapter. for details) communication elements Unstable explosives According to the
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Overview on EFSA data requirements for the safety evaluation of food enzymes applications
Overview on EFSA data requirements for the safety evaluation of food enzymes applications Fidel Toldrá and Klaus-Dieter Jany EFSA CEF Panel Info session on Food Enzymes applications Parma, 27 May 2014
Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines
Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines TABLE OF CONTENTS GUIDANCE DOCUMENT ON REVISIONS TO OECD GENETIC TOXICOLOGY TEST GUIDELINES... 1 1 GENERAL INTRODUCTION (PREAMBLE)...
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
GHS CLP ATREAT. The new classification and labelling of hazardous chemicals. Providing a single source for your water treatment chemicals
GHS CLP The new classification and labelling of hazardous chemicals ATREAT Providing a single source for your water treatment chemicals Dear customer The current European system for classification and
WHMIS After GHS: Preparing for Change. Canadian Centre for Occupational Health and Safety
WHMIS After GHS: Preparing for Change Canadian Centre for Occupational Health and Safety 1. About this publication WHMIS is changing. The substance of WHMIS (labels, MSDSs, and training) will remain, but
GHS Overview UN GHS and Country Implementation Overviews
GHS Overview UN GHS and Country Implementation Overviews Jytte Syska, 3E Company What is the GHS? Globally Harmonized System of Classification and Labelling of Chemicals A common and coherent United Nations
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS
GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS -ii- GUIDELINES ON THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND
BioSci 2200 General Genetics Problem Set 1 Answer Key Introduction and Mitosis/ Meiosis
BioSci 2200 General Genetics Problem Set 1 Answer Key Introduction and Mitosis/ Meiosis Introduction - Fields of Genetics To answer the following question, review the three traditional subdivisions of
Overview of Key Obligations Under Regulation (EC) No. 1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures (CLP)
Overview of Key Obligations Under Regulation (EC) No. 1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures (CLP) Summary This document examines the key aspects of the CLP
PART 4 ENVIRONMENTAL HAZARDS - 217 -
PART 4 ENVIRONMENTAL HAZARDS - 217 - CHAPTER 4.1 HAZARDOUS TO THE AQUATIC ENVIRONMENT 4.1.1 Definitions and general considerations 4.1.1.1 Definitions aquatic toxicity means the intrinsic property of
HAZARD COMMUNICATION & THE GLOBAL HARMONIZING SYSTEM EMPLOYEE TRAINING
HAZARD COMMUNICATION & THE GLOBAL HARMONIZING SYSTEM EMPLOYEE TRAINING This easy-to-use Leader s Guide is provided to assist in conducting a successful presentation. Featured are: INTRODUCTION: A brief
IMPURITIES IN NEW DRUG PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current
EFSA explains the carcinogenicity assessment of glyphosate
PESTICIDES UNIT EFSA explains the carcinogenicity assessment of glyphosate Background 12 November 2015 During the EFSA peer-review process for the renewal of the approval of the pesticide active substance
Authorisation and Restriction Newsletter
Authorisation and Restriction Newsletter August 2010, N 1 The information contained in this document is intended for guidance only and whilst the information is provided in utmost good faith and has been
ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5
European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS
1. When new cells are formed through the process of mitosis, the number of chromosomes in the new cells
Cell Growth and Reproduction 1. When new cells are formed through the process of mitosis, the number of chromosomes in the new cells A. is half of that of the parent cell. B. remains the same as in the
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Environmental Safety Division University of Georgia Right to Know Training
Course Overview All UGA employees are required to have basic Right To Know training for their protection. This course is designed to familiarize you with the basics of the Right to Know law covering university
Section 4. Toxicology
Section 4 Toxicology Occupational Health Any chemical you use incorrectly can result in over-exposure leading to adverse health effects immediately or in the future. All hazardous materials can be handled
The Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Hazard communication
The Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Hazard communication The contents of this presentation have been updated according to the sixth revised edition of the
GHS implementation in EU - The CLP Regulation -
GHS implementation in EU - The CLP Regulation - Lennart Dock [email protected] Swedish Chemicals Agency GHS Stocktaking Workshop for Central and Eastern Europe Chisinau, Republic of Moldova 7-9 July
GHS - GLOBALLY HARMONIZED SYSTEM
GHS - GLOBALLY HARMONIZED SYSTEM of Classification and Labelling of Chemicals GHS is a system proposed by the United Nations (UN) for the harmonised world-wide classification and labelling of chemical
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:
Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic
MUTATION, DNA REPAIR AND CANCER
MUTATION, DNA REPAIR AND CANCER 1 Mutation A heritable change in the genetic material Essential to the continuity of life Source of variation for natural selection New mutations are more likely to be harmful
Chapter 13: Meiosis and Sexual Life Cycles
Name Period Concept 13.1 Offspring acquire genes from parents by inheriting chromosomes 1. Let s begin with a review of several terms that you may already know. Define: gene locus gamete male gamete female
GUIDANCE ON A STRATEGY FOR GENOTOXICITY TESTING OF CHEMICAL SUBSTANCES
GUIDANCE ON A STRATEGY FOR GENOTOXICITY TESTING OF CHEMICAL SUBSTANCES CONTENTS PARAGRAPH I. Preface 1-5 II. Introduction 6-10 III. Significance of Chemical Induced Mutation for Human Health 11-12 IV.
ZOVIRAX Cold Sore Cream
Data Sheet ZOVIRAX Cold Sore Cream Aciclovir 5% w/w Presentation Topical cream Indications ZOVIRAX Cold Sore Cream is indicated for the treatment of Herpes simplex virus infections of the lips and face
Globally Harmonized System Pictogram Reference Table
The following summarizes new label elements per the GHS classification guidelines. Each summary describes the previous label element compared to the new, and may include examples of the new elements. The
HAZARD COMMUNICATION: NEW LABEL ELEMENTS AND SAFETY DATA SHEET (SDS) FORMAT
HAZARD COMMUNICATION: NEW LABEL ELEMENTS AND SAFETY DATA SHEET (SDS) FORMAT AGENDA Hazard Communication Recent Changes Pictograms New Label Format Signal Word Safety Data Sheets 2 HAZARD COMMUNICATION:
1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Conclusion No cytotoxicity can be detected at concentrations up to 100%.
Endotoxicity and Cytotoxicity Studies 1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Chinese Hamster Ovary (CHO) cells were grown in monolayer with and without metabolic activation.
HAZARD COMMUNICATION PROGRAM. Raul F. Garcia-Casariego CSP, CHMM Industrial Hygienist
HAZARD COMMUNICATION PROGRAM Raul F. Garcia-Casariego CSP, CHMM Industrial Hygienist PURPOSE To protect our workers by informing them of the presence and properties of hazardous chemicals in the workplace.
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC
Guidance document for the classification of dangerous goods with regard to their "corrosive effect on living tissue"
Guidance document for the classification of dangerous goods with regard to their "corrosive effect on living tissue" Updated guidance document of the BfR published on 12 June 2012 This guidance document
LITHIUM CARBONATE, 1% AQUEOUS
Material Safety Data Sheet LITHIUM CARBONATE, 1% AQUEOUS Section 1 - Chemical Product and Company Identification MSDS Name: Lithium Carbonate, 1% Aqueous Catalog Numbers: SO-721 Company Identification:
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Chemical Risk Assessment in Absence of Adequate Toxicological Data
Chemical Risk Assessment in Absence of Adequate Toxicological Data Mark Cronin School of Pharmacy and Chemistry Liverpool John Moores University England [email protected] The Problem Risk Analytical
2,2,2 trifluoroethanol
GPS Safety Summary 2,2,2 trifluoroethanol Chemical Identity Brand names 2,2,2 trifluoroethanol CAS number 75 89 8 Chemical name (IUPAC) 2,2,2 trifluoroethanol Molecular formula CF 3 CH 2 OH Synonyms TFE;
Adipic acid. GPS Safety Summary. Chemical Identity. Applications. Safety Assessment, Exposure and Risk Management Recommendations
GPS Safety Summary Chemical Identity Adipic acid Brand names Rhodiacid AA - Adipic acid CAS number 124-04-9 Chemical name (IUPAC) Hexanedioic acid Molecular formula C 6 H 10 O 4 Synonyms 1,6-Hexanedioic
Copyright@United Nations 2013. All rights reserved PART 4 ENVIRONMENTAL HAZARDS
PART 4 ENVIRONMENTAL HAZARDS CHAPTER 4.1 HAZARDOUS TO THE AQUATIC ENVIRONMENT 4.1.1 Definitions and general considerations 4.1.1.1 Definitions Acute aquatic toxicity means the intrinsic property of a
Safety data sheet according to 1907/2006/EC, Article 31
Page 1/6 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier Article number: 12000527, 12000528, 12000529, 12000530, 12000531 1.2 Relevant identified
Occupational Health and Safety. Changes to WHMIS Legislation
Occupational Health and Safety Bulletin Changes to WHMIS Legislation This document is intended to provide Alberta employers and workers with an update on changes to WHMIS legislation. It is important for
GPS Safety Summary. Tert-butyl 2-ethylhexaneperoxoate
GPS Safety Summary Substance Name: Tert-butyl 2-ethylhexaneperoxoate 1. General Statement Tert-Butyl peroxy-2-ethylhexanoate is primarily used is in the manufacture of polymers, as a polymerisation initiator.
National Standard of the People's Republic of China
ICS 71.040.40 G04 GB National Standard of the People's Republic of China GB/T 16483-2008 To Replace GB/T 17519.1-1998,GB 16483-2000 Safety Data Sheet for Chemical Products Content and Order of Sections
Guidance on information requirements and chemical safety assessment. Chapter R.2: Framework for generation of information on intrinsic properties
Guidance on information requirements and chemical safety assessment Chapter R.2: Framework for generation of information on intrinsic properties Version 2.1 December 2011 1 LEGAL NOTICE This document contains
Risk assessment and regulation of tattoo inks in the EU
Risk assessment and regulation of tattoo inks in the EU Paul Janssen Current situation: Tattoo application in a regulatory vacuum : Is not a medical treatment Is not a cosmetic treatment No EU-regulation
CLP CLASSIFICATION, LABELLING AND PACKAGING REGULATION 1272/2008/EC
CLP CLASSIFICATION, LABELLING AND PACKAGING REGULATION 1272/2008/EC Objectives Bit of History. Where are we now? What does it mean to us? What will we see? What should we start to do now? Lets see why
COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE PRE-CLINICAL EVALUATION OF ANTICANCER MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit London, 23 July 1998 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE PRE-CLINICAL
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
LECTURE 6 Gene Mutation (Chapter 16.1-16.2)
LECTURE 6 Gene Mutation (Chapter 16.1-16.2) 1 Mutation: A permanent change in the genetic material that can be passed from parent to offspring. Mutant (genotype): An organism whose DNA differs from the
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
September 19, 1984 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM
Agriculture Canada September 19, 1984 T-1-245 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM RE: Guidelines for Developing
This document includes the following letters of interpretation, memorandums, and questions and answers:
Collection of OSHA letters, memos, and Q&As within the date range 03/26/2012 to 03/05/2015 related to the Hazard Communication Standard, 29 CFR 1910.1200 This document includes the following letters of
Name: Class: Date: ID: A
Name: Class: _ Date: _ Meiosis Quiz 1. (1 point) A kidney cell is an example of which type of cell? a. sex cell b. germ cell c. somatic cell d. haploid cell 2. (1 point) How many chromosomes are in a human
Hydroquinone. Chemical Identity. Applications. Safety Assessment, Exposure and Risk Management Recommendations
GPS Safety Summary Contacts Hydroquinone Chemical Identity Brand names Hydroquinone CAS number 123-31-9 Chemical name (IUPAC) benzene-1,4-diol Molecular formula C 6H 6O 2 Synonyms Para-hydroxyphenol; 1,4-dihydroxybenzol;
Safety Data Sheet. Document Group: 10-4849-5 Version Number: 11.01 Issue Date: 05/26/15 Supercedes Date: 10/09/14
3M FT-10 Qualitative Fit Test Kit, Sweet 05/26/15 Safety Data Sheet Copyright,2015,3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing
HSE: Frequently Asked Questions
HSE: Frequently Asked Questions Q1 - What is GHS? A GHS refers to the United Nations (UN) Globally Harmonised System of Classification and Labelling of Chemicals. The UN published GHS in its publication
AMES TEST: Bacterial Reverse Mutation Assay
AMES TEST: Bacterial Reverse Mutation Assay 1. Introduction The bacteria reversed mutation assay (Ames Test) is used to evaluate the mutagenic properties of test articles. The test uses amino acid-dependent
GPS Product Safety Summary
Document Number: GPSSR-106 SULFONIC ACIDS, C14-17-SEC-ALKANE, SODIUM SALTS GENERAL STATEMENT GPS summary is intended to provide a general overview of the chemical substances in context of ICCA Global Product
3M Flip-Top Dilution Bottle - Peptone Water (formerly Biotrace Flip Top Dilution Bottles, 99ml Peptone Water) 07/31/15
Safety Data Sheet Copyright,2015,3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing 3M products is allowed provided that: (1) the information
dixa a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University
dixa a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University Current protocol for chemical safety testing Short Term Tests for Genetic Toxicity Bacterial Reverse
Chapter 13: Meiosis and Sexual Life Cycles
Name Period Chapter 13: Meiosis and Sexual Life Cycles Concept 13.1 Offspring acquire genes from parents by inheriting chromosomes 1. Let s begin with a review of several terms that you may already know.
Risk Assessment Report on (3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE (CHPTAC)
Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on (3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE (CHPTAC) Human Health Part CAS No.: 3327-22-8 EINECS No.: 222-048-3
Globally Harmonized System: Labeling & Safety Data Sheets. Leader s Guide
4253 Globally Harmonized System: Labeling & Safety Data Sheets Leader s Guide Globally Harmonized System (GHS) and the OSHA Hazard Communication Standard The Occupational Safety and Health Administration
Safety Data Sheet. SECTION 1: Identification. SECTION 2: Hazard identification
Safety Data Sheet Copyright,2014,3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing 3M products is allowed provided that: (1) the information
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
NONCLINICAL EVALUATION FOR ANTICANCER PHARMACEUTICALS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE NONCLINICAL EVALUATION FOR ANTICANCER PHARMACEUTICALS
Training Requirements for the Revised Hazard Communication Standard
www.alterisus.com Training Requirements for the Revised Hazard Communication Standard As of December 1, 2013 OSHA revised its Hazard Communication Standard (HCS) to align with the United Nations Globally
Genetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes.
Genetic Mutations Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes. Agenda Warm UP: What is a mutation? Body cell? Gamete? Notes on Mutations Karyotype Web Activity
